Related Experiment Video
Updated: Jul 21, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
Effect of probiotics on necrotizing enterocolitis in preterm infants: a network meta-analysis of randomized
Yu Dai1, Qinlei Yu1, Fan Zhang1
1Department of Pediatrics, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, 123 Tian Fei Xiang, Mo Chou Road, Nanjing, 210004, China.
Insights
Probiotics significantly reduce necrotizing enterocolitis (NEC) and mortality in preterm infants. Specific combinations, like Bifidobacterium, Lactobacillus, and Enterococcus, show the most promise for improved outcomes and shorter hospital stays.
Area of Science:
- Neonatal Medicine
- Microbiome Research
- Clinical Nutrition
Background:
- Previous research suggests probiotics offer benefits for preterm infants, but efficacy varies by strain.
- Necrotizing enterocolitis (NEC) remains a significant concern in preterm infant care.
- The optimal probiotic strategy for preterm infants requires further investigation.
Purpose of the Study:
- To evaluate the efficacy of various probiotics in preventing NEC and related outcomes in preterm infants.
- To conduct a network meta-analysis comparing different probiotic interventions against placebo.
- To identify specific probiotic species or combinations with the greatest clinical benefit.
Main Methods:
- Network meta-analysis of 51 randomized controlled trials.
- Inclusion of 11,661 preterm infants.
- Assessment of outcomes including NEC incidence, mortality, hospital stay, and feeding advancement.
Main Results:
- Most probiotics reduced NEC incidence (Bell's stage II or higher).
- Specific combinations (Bifidobacterium, Lactobacillus, Streptococcus) significantly reduced all-cause mortality.
- Lactobacillus alone shortened hospital stays and accelerated full enteral feeding.
Conclusions:
- The combination of Bifidobacterium, Lactobacillus, and Enterococcus demonstrated the highest efficacy in reducing NEC and mortality.
- Prebiotics and Lactobacillus monotherapy effectively reduced hospitalization duration and time to full enteral feeding.
- Probiotics did not show a significant impact on sepsis risk in this analysis.
Background:
Previous studies have suggested that probiotics may have potential benefits for preterm infants. Their efficacy seems to depend on the particular species or combinations used.
Methods:
To further investigate the effects of probiotics in preventing necrotizing enterocolitis (NEC) and other related outcomes in preterm infants, we conducted a network meta-analysis of 51 randomized controlled trials involving 11,661 participants.
Results:
Our study revealed that most probiotics can effectively reduce the incidence of NEC (at or beyond Bell's stage II). Lactobacillus (RR, 0.59; 95% CI: 0.29, 0.98), the combination of Bifidobacterium and Lactobacillus (RR, 0.47; 95% CI: 0.20, 0.87), and the combination of Bifidobacterium, Lactobacillus, and Streptococcus (RR, 0.17; 95% CI: 0.00, 0.84) were the only treatments that significantly reduced all-cause mortality compared to placebo. Lactobacillus can be effective in reducing the time preterm infants spend in the hospital (MD, -4.23; 95% CI: -7.62, -0.81) and reaching full enteral feeding (MD, -2.15; 95% CI: -3.70, -0.64).
Conclusions:
The combination of Bifidobacterium, Lactobacillus, and Enterococcus was the most efficacious in reducing the mortality and incidence of NEC (Bell II or above) in preterm infants. Both prebiotics and Lactobacillus alone were found to be highly effective in reducing the length of hospitalization and the time needed to achieve full enteral feeding. No evidence suggests that probiotics affect sepsis risk.
Trial Registration:
The study protocol was registered with PROSPERO (CRD42023460231) on March 10, 2023.
Related Concept Videos
Probiotics
Development of Human Microbiota
Microbiota Modulation by Antibiotics

